Melanoma management

Keyphrases

Publications

volume 11, number 1, 2024

Alexander Witkowski, Abel D Jarell, Kelli L Ahmed, Jennifer J Siegel, Brooke H Russell, Jason H Rogers, Matthew S Goldberg, Neil F Fernandes, Joanna Ludzik, Aaron S Farberg
A clinical impact study of dermatologists' use of diagnostic gene expression profile testing to guide patient management. Melanoma management 11 (1) (2024)
Alexander Witkowski, Abel D Jarell, Kelli L Ahmed, Jennifer J Siegel, Brooke H Russell, Jason H Rogers, Matthew S Goldberg, Neil F Fernandes, Joanna Ludzik, Aaron S Farberg
A clinical impact study of dermatologists' use of diagnostic gene expression profile testing to guide patient management. Melanoma management 11 (1) (2024)

volume 10, number 2, 2024

Li Yang, Zi-Jian Cao, Yuan Zhang, Jin-Ke Zhou, Jun Tian
Disulfidptosis-related classification patterns and tumor microenvironment characterization in skin cutaneous melanoma. Melanoma management 10 (2) (2024)
Li Yang, Zi-Jian Cao, Yuan Zhang, Jin-Ke Zhou, Jun Tian
Disulfidptosis-related classification patterns and tumor microenvironment characterization in skin cutaneous melanoma. Melanoma management 10 (2) (2024)

volume 10, number 3, 2024

volume 10, number 4, 2024

Olanrewaju Olapeju, Jonathan Shakesprere, Carie Boykin, Patrick Bacaj, Mohamad Salkini, Joanna Kolodney
Primary malignant melanoma of the genitourinary tract: case series of a rare form of primary mucosal melanoma. Melanoma management 10 (4) (2024)
Olanrewaju Olapeju, Jonathan Shakesprere, Carie Boykin, Patrick Bacaj, Mohamad Salkini, Joanna Kolodney
Primary malignant melanoma of the genitourinary tract: case series of a rare form of primary mucosal melanoma. Melanoma management 10 (4) (2024)

volume 10, number 1, 2023

volume 9, number 3, 2022

Basil K Williams, Jennifer J Siegel, Katherina M Alsina, Lauren Johnston, Amanda Sisco, Kyleigh LiPira, Sara M Selig, Peter G Hovland
Uveal melanoma patient attitudes towards prognostic testing using gene expression profiling. Melanoma management 9 (3) (2022)

volume 8, number 4, 2022

Léa El Haddad, Tarek Souaid, Diana Kadi, Joya-Rita Hindy, Karim Souaid, Hampig Raphael Kourie, Roland Tomb
Knowledge and behavior of Lebanese parents regarding melanoma prevention in public and private school children. Melanoma management 8 (4) (2022)

volume 8, number 1, 2021

Yusuf Yagmur, Mehmet Ali Açıkgöz
Metastatic melanoma causing recurrent intussusception and perforation of small bowel: case reports and literature review. Melanoma management 8 (1) (2021)

volume 8, number 2, 2021

Karam Khaddour, Tanner M Johanns, George Ansstas
BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma. Melanoma management 8 (2) (2021)
Tawnya L Bowles, Carol Sweeney, John Snyder, Jesse Gygi, Brad Bott, Daniel Wray, Timothy J Yeatman, William T Sause
Impact of rurality on melanoma diagnosis in Utah. Melanoma management 8 (2) (2021)

volume 8, number 3, 2021

Matthew J Hadfield, Alla Turshudzhyan, Jane M Grant-Kels
Evolving treatments and future therapeutic targets in desmoplastic melanoma. Melanoma management 8 (3) (2021)
Kermit S Zhang, Tomer Pelleg, Sabrina Campbell, Catalina Rubio, Anthony Lukas Loschner, Susanti Ie
Pulmonary metastatic melanoma: current state of diagnostic imaging and treatments. Melanoma management 8 (3) (2021)

volume 8, number 1, 2020

Eric A Deckers, Marieke Wj Louwman, Schelto Kruijff, Harald J Hoekstra
Letter in reply: increase of sentinel lymph node melanoma staging in The Netherlands; still room and need for further improvement. Melanoma management 8 (1) (2020)
Harmanjit Singh, Anjelli Wignakumar, Georgina J Williams, Shima Jamshidi, Daniel P Butler, Simon H Wood, Navid Jallali, Jonathan A Dunne
Increase of sentinel lymph node melanoma staging in The Netherlands: still room and need for further improvement. Melanoma management 8 (1) (2020)

volume 7, number 1, 2020

Amy C Schefler, Alison Skalet, Scott Cn Oliver, John Mason, Anthony B Daniels, Katherina M Alsina, Kristen M Plasseraud, Federico A Monzon, Brian Firestone
Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling. Melanoma management 7 (1) (2020)
Rachael Miller, Sophie Walker, Irene Shui, Agnes Brandtmüller, Kevin Cadwell, Emilie Scherrer
Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review. Melanoma management 7 (1) (2020)
Quaovi H Sodji, Paulina M Gutkin, Susan M Swetter, Sunil A Reddy, Susan M Hiniker, Susan J Knox
Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab. Melanoma management 7 (1) (2020)
Alessia Visconti, Marianna Sanna, Veronique Bataille, Mario Falchi
Genetics plays a role in nevi distribution in women. Melanoma management 7 (1) (2020)
Eric A Deckers, Marieke Wj Louwman, Schelto Kruijff, Harald J Hoekstra
Increase of sentinel lymph node melanoma staging in The Netherlands; still room and need for further improvement. Melanoma management 7 (1) (2020)
Caitlin Killen
Welcome to volume 7 of Melanoma Management. Melanoma management 7 (1) (2020)

volume 7, number 2, 2020

Enrique Boldo, Araceli Mayol, Rafael Lozoya, Alba Coret, Diana Escribano, Carlos Fortea, Andres Muñoz, Juan Carlos Pastor, Guillermo Perez De Lucia
Laparoscopically assisted ilio-inguinal lymph node dissection versus inguinal lymph node dissection in melanoma. Melanoma management 7 (2) (2020)
Alexandra Ikeguchi, Michael Machiorlatti, Sara K Vesely
Disparity in outcomes of melanoma adjuvant immunotherapy by demographic profile. Melanoma management 7 (2) (2020)
Lorenzo Salvati, Mario Mandala, Daniela Massi
Melanoma brain metastases: review of histopathological features and immune-molecular aspects. Melanoma management 7 (2) (2020)
Ursula E Lang
Primary cilia: putting a sensor on the underlying melanocytic tumor cell state. Melanoma management 7 (2) (2020)
James Sun, Brian R Gastman, Lucy McCahon, Elizabeth I Buchbinder, Igor Puzanov, Michele Nanni, James M Lewis, Richard D Carvajal, Shahnaz Singh-Kandah, Anupam M Desai, Leon Raskin, Carrie M Nielson, Rubina Ismail, Jonathan S Zager
Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2). Melanoma management 7 (2) (2020)

volume 7, number 3, 2020

Robert O Dillman
An update on GM-CSF and its potential role in melanoma management. Melanoma management 7 (3) (2020)
James Randall Patrinley, Douglas B Johnson
Pandemic medicine: the management of advanced melanoma during COVID-19. Melanoma management 7 (3) (2020)
Russell J Diefenbach, Jenny H J Lee, Helen Rizos
Methylated circulating tumor DNA as a biomarker in cutaneous melanoma. Melanoma management 7 (3) (2020)
Joshua T Cohen, Thomas J Miner, Michael P Vezeridis
Is the neutrophil-to-lymphocyte ratio a useful prognostic indicator in melanoma patients? Melanoma management 7 (3) (2020)
Enrico Zelin, Conforti Claudio, Roberta Giuffrida, Teresa Deinlein, Nicola Di Meo, Iris Zalaudek
Melanoma in pregnancy: certainties unborn. Melanoma management 7 (3) (2020)

volume 7, number 4, 2020

Gregory S Mellotte, Diya Sabu, Mary O'Reilly, Ray McDermott, Anthony O'Connor, Barbara M Ryan
The challenge of primary gastric melanoma: a systematic review. Melanoma management 7 (4) (2020)
Neil K Jairath, Mark W Farha, Ruple Jairath, Kelly L Harms, Lam C Tsoi, Trilokraj Tejasvi
Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma. Melanoma management 7 (4) (2020)

volume 6, number 3, 2019

David E Gyorki, Jonathan S Zager
Locoregional melanoma: identifying optimal care in a rapidly changing landscape. Melanoma management 6 (3) (2019)
Michael A Henderson
Topical and intralesional therapies for in-transitmelanoma. Melanoma management 6 (3) (2019)
Jennifer S Downs, David E Gyorki
An evidence-based approach to positive sentinel node disease: should we ever do a completion node dissection? Melanoma management 6 (3) (2019)

volume 6, number 4, 2019

Douglas Grossman, Caroline C Kim, Rebecca I Hartman, Elizabeth Berry, Kelly C Nelson, Nwanneka Okwundu, Clara Curiel-Lewandrowski, Sancy A Leachman, Susan M Swetter
Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice. Melanoma management 6 (4) (2019)
Fernanda Faião-Flores, Keiran Sm Smalley
Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma? Melanoma management 6 (4) (2019)
Ester Simeone, Antonio M Grimaldi, Lucia Festino, Claudia Trojaniello, Maria G Vitale, Vito Vanella, Marco Palla, Paolo A Ascierto
Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management. Melanoma management 6 (4) (2019)
Shweta Shah, Leon Raskin, David Cohan, Omid Hamid, Morganna L Freeman
Treatment patterns of melanoma by BRAF mutation status in the USA from 2011 to 2017: a retrospective cohort study. Melanoma management 6 (4) (2019)
Peter Mohr, Felix Kiecker, Virtudes Soriano, Olivier Dereure, Karmele Mujika, Philippe Saiag, Jochen Utikal, Rama Koneru, Caroline Robert, Florencia Cuadros, Matias Chacón, Rodrigo U Villarroel, Yana G Najjar, Lisa Kottschade, Eva M Couselo, Roy Koruth, Annie Guérin, Rebecca Burne, Raluca Ionescu-Ittu, Maurice Perrinjaquet, Jonathan S Zager
Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review. Melanoma management 6 (4) (2019)

Melanoma management

Keyphrases

Publications

volume 11, number 1, 2024

volume 10, number 2, 2024

volume 10, number 3, 2024

volume 10, number 4, 2024

volume 10, number 1, 2023

volume 9, number 4, 2023

volume 9, number 1, 2022

volume 9, number 2, 2022

volume 9, number 3, 2022

volume 8, number 4, 2022

volume 8, number 1, 2021

volume 8, number 2, 2021

volume 8, number 3, 2021

volume 8, number 1, 2020

volume 7, number 1, 2020

volume 7, number 2, 2020

volume 7, number 3, 2020

volume 7, number 4, 2020

volume 6, number 3, 2019

volume 6, number 4, 2019